TVRD — Tvardi Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapSucker Stock

Annual balance sheet for Tvardi Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	R2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	167	145	101	31.6	30.8
Net Total Accounts Receivable
Net Total Receivables	1.15	4.45	4.02	—	—
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	173	169	116	31.7	31.5
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	3.6	1.98	8.19	0.3	0.196
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	247	182	126	35.2	32.1
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Current Liabilities	17.6	23.5	25.6	10.4	11
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	19.5	23.5	68.8	40.8	11.1
Redeemable Preferred Stock
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	228	159	57.1	-5.63	20.9
Total Liabilities & Shareholders' Equity	247	182	126	35.2	32.1
Total Common Shares Outstanding